Cargando…

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice

Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24) encodes a tumor suppressor gene implicated in the growth of various tumor types including breast cancer. We previously demonstrated that recombinant adenovirus-mediated mda-7/IL-24 expression in the mammary glands of carcinogen-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, You-Jun, Liu, Guodong, Xia, Lei, Xiao, Xiao, Liu, Jeff C., Menezes, Mitchell E., Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, Fisher, Paul B., Archer, Michael C., Zacksenhaus, Eldad, Ben-David, Yaacov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741907/ https://www.ncbi.nlm.nih.gov/pubmed/26460950

Ejemplares similares

MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2015)

MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2016)

Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells
por: Talukdar, Sarmistha, et al.
Publicado: (2016)

Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis
por: Das, Swadesh K., et al.
Publicado: (2016)

Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic
por: Sarkar, Siddik, et al.
Publicado: (2015)

Regulation of neuroblastoma migration, invasion and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin
por: Bhoopathi, Praveen, et al.
Publicado: (2019)

MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
por: Talukdar, Sarmistha, et al.
Publicado: (2019)

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking
por: Pradhan, Anjan K., et al.
Publicado: (2019)

AEG-1–AKT2: A novel complex controlling the aggressiveness of glioblastoma
por: Emdad, Luni, et al.
Publicado: (2015)

Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma
por: Rajesh, Yetirajam, et al.
Publicado: (2020)

Developmental and Lactational Exposure to Dieldrin Alters Mammary Tumorigenesis in Her2/neu Transgenic Mice
por: Cameron, Heather L., et al.
Publicado: (2009)

Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status
por: Soares, Maria, et al.
Publicado: (2016)

Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
por: Provinciali, Mauro, et al.
Publicado: (2017)

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
por: Boggio, Katia, et al.
Publicado: (1998)

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
por: Bandini, Silvio, et al.
Publicado: (2013)

Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein
por: Modi, Jinkal, et al.
Publicado: (2021)

Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis
por: Mancini, Maria L., et al.
Publicado: (2016)

A Tumor initiating cell-enriched prognostic signature for HER2(+):ERα(−) breast cancer; rationale, new features, controversies and future directions
por: Liu, Jeff C., et al.
Publicado: (2013)

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice
por: Nanni, Patrizia, et al.
Publicado: (2001)

Identification of Genes Potentially Regulated by Human Polynucleotide Phosphorylase (hPNPase(old-35)) Using Melanoma as a Model
por: Sokhi, Upneet K., et al.
Publicado: (2013)

Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation
por: Liu, Jeff C., et al.
Publicado: (2016)

Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis
por: Fry, Elizabeth A., et al.
Publicado: (2013)

Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer
por: Rajput, Shashi, et al.
Publicado: (2013)

Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
por: Jiang, Zhe, et al.
Publicado: (2002)

Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8(+) T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice
por: Chen, Y, et al.
Publicado: (2011)

Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
por: Pathangey, Latha B., et al.
Publicado: (2016)

Targeting HER2(+) breast cancer: the TBK1/IKKε axis
por: Jiang, Zhe, et al.
Publicado: (2014)

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015)

Intraductal pegylated liposomal doxirubicin may achieve long term protection in HER2/NEU transgenic mice by restricting mammary gland outgrowth
por: Sukumar, S, et al.
Publicado: (2009)

Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer
por: Wang, Sharon, et al.
Publicado: (2016)

Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells
por: Hamed, Hossein A, et al.
Publicado: (2013)

Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
por: Pradhan, Anjan K., et al.
Publicado: (2022)

Fusion between cancer cells and macrophages occurs in a murine model of spontaneous neu(+) breast cancer without increasing its metastatic potential
por: Lizier, Michela, et al.
Publicado: (2016)

Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis
por: Patel, Y, et al.
Publicado: (2018)

Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging
por: Bhoopathi, Praveen, et al.
Publicado: (2021)

The ets transcription factor Fli-1 in development, cancer and disease
por: Li, Youjun, et al.
Publicado: (2014)

Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis, radiosensitization, and overcomes temozolomide resistance in malignant gliomas
por: Germano, Isabelle M., et al.
Publicado: (2010)

Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells
por: Kim, Aeree, et al.
Publicado: (2005)

Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine
por: Quinn, Bridget A., et al.
Publicado: (2016)

Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter
por: Bhoopathi, Praveen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i8jj1a5q4gqu9mf3nl5r022pld